Symptomatic HIV infection and in-hospital outcomes for patients with acute myocardial infarction undergoing percutaneous coronary intervention from national inpatient sample

Mingzhi Cui,Haohong Qi,Ting Zhang,Shixiong Wang,Xiao Zhang,Xiangmei Cao,Xueping Ma,Hui Huang,Ru Yan,Shaobin Jia,Guangzhi Cong
DOI: https://doi.org/10.1038/s41598-024-59920-9
IF: 4.6
2024-04-30
Scientific Reports
Abstract:Human immunodeficiency virus (HIV) infection increases the risk of acute myocardial infarction (AMI). However, little is known about its association with in-hospital outcomes and temporal trends in patients with AMI undergoing percutaneous coronary intervention (PCI). We queried patients with AMI who underwent PCI from the National Inpatient Sample Database (2003–2015) and stratified them into three groups: symptomatic, asymptomatic, and HIV-negative. After 1:2 case–control matching (CCM), logistic regression analysis was conducted to determine how HIV infection affected in-hospital outcomes. We also evaluated their recent trends from 2003 to 2015. The total weighted national estimate of 2,191,129 AMI cases included 2,178,995 HIV/AIDS-negative, 4994 asymptomatic, and 7140 symptomatic HIV cases. Symptomatic but not asymptomatic patients with HIV suffered more than triple the in-hospital mortality (adjusted odds ratio (aOR) 3.6, 95% confidence interval (CI) 2.5–5.2), over one-fold incidence of acute kidney injury (aOR 2.6 95% CI 1.9–3.4) and cardiogenic shock risk (aOR 1.9, 95% CI 1.3–2.7), a longer length of hospital stay (beta 1.2, 95% CI 1.0–1.5), and had more procedures (beta 1.3, 95% CI 1.2–1.5). These disparities relating to symptomatic HIV infection persisted from 2003 to 2015. In patients with AMI who underwent PCI, symptomatic HIV infection was associated with higher in-hospital mortality and more severe outcomes.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the impact of human immunodeficiency virus (HIV) infection on the in - hospital outcomes of patients with acute myocardial infarction (AMI) during percutaneous coronary intervention (PCI) and its changing trend over time. Specifically, the study aims to evaluate: 1. **The relationship between HIV infection status and in - hospital outcomes**: By analyzing the data in the National Inpatient Sample (NIS) database from 2003 to 2015, the researchers explored whether HIV infection (especially symptomatic HIV infection) would affect the in - hospital mortality and other adverse in - hospital outcomes (such as acute kidney injury, cardiogenic shock, prolonged hospital stay and increased number of operations) of AMI patients after receiving PCI treatment. 2. **Differences in in - hospital outcomes among patients with different HIV infection statuses**: The study divided patients into three groups: symptomatic HIV infection, asymptomatic HIV infection and HIV - negative. After adjusting for confounding factors such as age, gender, smoking status and comorbidities by the 1:2 case - control matching (CCM) method, the in - hospital outcomes among the groups were compared. 3. **The time trend of the impact of HIV infection on in - hospital outcomes**: The study also evaluated whether there were changes in the impact of HIV infection on the in - hospital outcomes of AMI patients from 2003 to 2015, in order to understand the long - term trend of this problem. Through these analyses, the study aims to provide evidence for clinicians about the higher risks that HIV - infected patients may face during PCI treatment during AMI, thereby helping to improve the management and treatment strategies for these patients.